news
A US study has overcome a major obstacle in cell-free…
7 July 2023 | By Izzy Wood (Drug Target Review)
A US study has overcome a major obstacle in cell-free DNA (cfDNA) testing or liquid biopsy, offering promising advancements in disease diagnosis and monitoring.